125 related articles for article (PubMed ID: 10567781)
1. Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers.
Allen A; Vousden M; Lewis A
Chemotherapy; 1999; 45(6):496-503. PubMed ID: 10567781
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of gemifloxacin on the steady-state pharmacokinetics of theophylline in healthy volunteers.
Davy M; Allen A; Bird N; Rost KL; Fuder H
Chemotherapy; 1999; 45(6):478-84. PubMed ID: 10567778
[TBL] [Abstract][Full Text] [Related]
3. Effect of Maalox on the bioavailability of oral gemifloxacin in healthy volunteers.
Allen A; Vousden M; Porter A; Lewis A
Chemotherapy; 1999; 45(6):504-11. PubMed ID: 10567782
[TBL] [Abstract][Full Text] [Related]
4. Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers.
Vousden M; Allen A; Lewis A; Ehren N
Chemotherapy; 1999; 45(6):485-90. PubMed ID: 10567779
[TBL] [Abstract][Full Text] [Related]
5. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
[TBL] [Abstract][Full Text] [Related]
6. The effect of ferrous sulphate and sucralfate on the bioavailability of oral gemifloxacin in healthy volunteers.
Allen A; Bygate E; Faessel H; Isaac L; Lewis A
Int J Antimicrob Agents; 2000 Aug; 15(4):283-9. PubMed ID: 10929878
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers.
Allen A; Bygate E; Oliver S; Johnson M; Ward C; Cheon AJ; Choo YS; Kim IC
Antimicrob Agents Chemother; 2000 Jun; 44(6):1604-8. PubMed ID: 10817716
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcium carbonate on bioavailability of orally administered gemifloxacin.
Pletz MW; Petzold P; Allen A; Burkhardt O; Lode H
Antimicrob Agents Chemother; 2003 Jul; 47(7):2158-60. PubMed ID: 12821462
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics and bioavailability of gemifloxacin administered as an intravenous 200 mg formulation or an oral 320 mg tablet.
Kim MJ; Lim HS; Cho SH; Bae KS
Clin Drug Investig; 2014 Mar; 34(3):195-201. PubMed ID: 24385283
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers.
Davy M; Bird N; Rost KL; Fuder H
Chemotherapy; 1999; 45(6):491-5. PubMed ID: 10567780
[TBL] [Abstract][Full Text] [Related]
11. The effect of food on the bioavailability of oral gemifloxacin in healthy volunteers.
Allen A; Bygate E; Clark D; Lewis A; Pay V
Int J Antimicrob Agents; 2000 Sep; 16(1):45-50. PubMed ID: 11185412
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin.
Vousden M; Ferguson J; Richards J; Bird N; Allen A
Chemotherapy; 1999; 45(6):512-20. PubMed ID: 10567783
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.
Gee T; Andrews JM; Ashby JP; Marshall G; Wise R
J Antimicrob Chemother; 2001 Apr; 47(4):431-4. PubMed ID: 11266415
[TBL] [Abstract][Full Text] [Related]
14. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
Ball P; Mandell L; Patou G; Dankner W; Tillotson G
Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Shinzato T; Doyle E; Edelstein MA
Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
[TBL] [Abstract][Full Text] [Related]
16. Effect of Maalox and omeprazole on the bioavailability of trovafloxacin.
Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():93-7. PubMed ID: 9222077
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone.
Sullivan JT; Woodruff M; Lettieri J; Agarwal V; Krol GJ; Leese PT; Watson S; Heller AH
Antimicrob Agents Chemother; 1999 Nov; 43(11):2793-7. PubMed ID: 10543767
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
Sethi S; Fogarty C; Fulambarker A
Respir Med; 2004 Aug; 98(8):697-707. PubMed ID: 15303633
[TBL] [Abstract][Full Text] [Related]
19. The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.
Ramji JV; Austin NE; Boyle GW; Chalker MH; Duncan G; Fairless AJ; Hollis FJ; McDonnell DF; Musick TJ; Shardlow PC
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):435-42. PubMed ID: 11259328
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE
J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
